Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE5415.40115.4 (+2.18 %)

PREV CLOSE ( ) 5300.00

OPEN PRICE ( ) 5381.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1499

TODAY'S LOW / HIGH ( )5349.25 5514.70

52 WK LOW / HIGH ( )3128.5 7208

NSE5425.8093.55 (+1.75 %)

PREV CLOSE( ) 5332.25

OPEN PRICE ( ) 5377.00

BID PRICE (QTY) 5425.80 (55)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 11479

TODAY'S LOW / HIGH( ) 5335.35 5520.00

52 WK LOW / HIGH ( )3125 7220.95

Chairman	Narayan K Seshadri
Managing Director	Sanjeev Kumar Panchal
Company Secretary	Manasa R
Non Executive Director	Ankush Nandra Hooi-Bien Chuah
Additional Director	Sylvia Lorena Varela Ramon
Non Executive Independent Director	Revathy Ashok Shilpa Shridhar Divekar
Whole Time Director	Bhavana Agrawal

Incorporation Year : 11-07 1979

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road Bengaluru,
Karnataka-560045 .

Phone : 080 6774 8000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX